Search

everythinglearnresearchcommunity

for

Search:↓

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Premature graying of hair may suggest health issues and currently lacks effective treatments.

A blood pressure drug, diltiazem, may also help treat influenza.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Use finasteride, minoxidil, and follicular unit transplantation for hair loss treatment.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Pregnancy can cause specific skin conditions that need correct diagnosis and treatment to protect both mother and baby.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Mutations in certain receptors can cause diseases and offer new treatment options.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Minoxidil in breast milk may harm nursing infants.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.